Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease

Endocrine. 2015 Feb;48(1):254-63. doi: 10.1007/s12020-014-0289-8. Epub 2014 May 23.

Abstract

The aim of this study was to evaluate the relationship of stressful events (SE) with the onset and outcome of Graves' disease (GD). Over a period of 21 years, we enrolled 58 consecutive patients in whom at least one SE had occurred ≤12 months before the onset of GD. Patients were treated with antithyroid drugs (ATD) for ≥12 months and followed up for ≥5 years after ATD withdrawal. We divided patients in three groups: REM (who reached remission; 25.9%); EXA (who experienced ≥1 exacerbation during ATD; 10.3%); and REL (who experienced ≥1 relapse after ATD withdrawal; 63.8%). The average age at onset was similar in the three groups. All males aged ≤25 years at GD onset relapsed at least once; no patient aged ≥51 years at GD onset relapsed ≥2 times. All patients who exacerbated or relapsed had at least one SE preceding each exacerbation or relapse. The time lag between SE and onset of GD (19.3±11.9 weeks) correlated with the age at onset (r=0.292, P=0.0002), particularly in the REL group (r=0.346, P=0.001). Overall, EXA and REL patients experienced more SE than REM patients (P=0.0002 and P=0.003, respectively). In the REL group, the overall number of SE was correlated with the number of relapses (r=0.486, P<0.0001). There exist GD patients who are prone to develop hyperthyroidism and its recurrences when exposed to SE. They are relatively young; the younger these patients are, the shorter is the time lag between SE and the onset of hyperthyroidism.

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Antithyroid Agents / therapeutic use
  • Child
  • Female
  • Graves Disease / complications
  • Graves Disease / drug therapy
  • Graves Disease / pathology*
  • Humans
  • Hyperthyroidism / etiology
  • Hyperthyroidism / pathology*
  • Male
  • Middle Aged
  • Recurrence
  • Sex Characteristics
  • Stress, Psychological / complications*
  • Treatment Outcome
  • Young Adult

Substances

  • Antithyroid Agents